相关实验视频

Updated: Jul 2, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

质母细胞瘤上皮肤生长因子受体抑制剂:目前的状况和未来的可能性

Shawyon Ezzati¹, Samuel Salib¹, Meenakshisundaram Balasubramaniam²

¹California Northstate University College of Medicine, Elk Grove, CA 95757, USA.

International journal of molecular sciences

|February 24, 2024

概括

向表皮生长因子受体 (EGFR) 为质母细胞瘤治疗提供了希望. 通过精准医学和组合疗法克服血脑屏障透和抵抗等挑战是改善患者治疗结果的关键.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
药物开发药物开发

背景情况:

质母细胞瘤 (世卫组织4级质母细胞瘤) 在成人初级脑瘤管理方面存在重大挑战.
皮表皮生长因子受体 (EGFR) 是一个关键的治疗点,在50%以上的质母细胞瘤病例中发现突变,包括EGFRvIII和EGFRvII等变体.

研究的目的:

审查利用小分子抑制剂和抗体针对表皮生长因子受体 (EGFR) 治疗质母细胞瘤的潜力.
探索克服治疗阻力和血脑屏障限制在质母细胞瘤的策略.

主要方法:

对EGFR突变,信号通路和质母细胞瘤治疗策略的当前文献的综述.
讨论新兴药物输送系统,包括纳米药物和对流增强输送.
探索用于患者分层和组合治疗方法的诊断工具.

主要成果:

EGFR抑制剂显示出有希望的结果,但在质母细胞瘤中面临障碍,包括血脑屏障的透和内在抵抗.
纳米药物和对流增强的输送提供了针对大脑药物输送的潜在解决方案.
放射性标记的抗EGFR抗体806i有助于可视化EGFR形状,以便量身定制的治疗选择.

结论:

精确瘤学,专注于定制的EGFR向治疗,是质母细胞瘤的一个有希望的途径.
有效的血脑屏障导航和针对下游途径 (mTOR,PI3k,HDACs) 的组合疗法对于提高疗效至关重要.

关键词:

生物疗法是一种生物疗法.皮肤上生长因子受体.质母细胞瘤是一种质母细胞瘤.分子异质性的分子异质性精确瘤学精确瘤学铁氨酸激酶酶的使用方法铁氨基激酶抑制剂铁氨基激酶抑制剂

更多相关视频

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Published on: September 26, 2011

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...